PETER SCHUMAN: Open Payments
NPI 1447242532 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,508 in 47 payments from 12 companies in 2025. Trend: 2023 $978 · 2024 $1,108 · 2025 $1,508
Food & beverage: $1,508
| Company | Payments | Amount |
|---|---|---|
| SPR Therapeutics, Inc | 20 | $337 |
| Saluda Medical Americas, Inc. | 7 | $259 |
| Nalu Medical, Inc. | 1 | $184 |
| SI-BONE, INC. | 4 | $160 |
| MERZ NORTH AMERICA, INC. | 1 | $149 |
| Novo Nordisk Inc | 1 | $119 |
| ABBVIE INC. | 4 | $97 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $65 |
| Boston Scientific Corporation | 2 | $58 |
| Bioventus LLC | 2 | $37 |
Products named: SPRINT PNS System, Evoke, Nalu Neurostimulation System, Wegovy, JOURNAVX, BOTOX, QULIPTA, WaveWriter Alpha Prime 16.
Industry payments across NY — which companies pay providers there.
